Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells
about
Tamoxifen Resistance: Emerging Molecular TargetsInsights into the key roles of proteoglycans in breast cancer biology and translational medicineEstrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancerVersican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomasThe motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans.Pregnancy-induced gingivitis and OMICS in dentistry: in silico modeling and in vivo prospective validation of estradiol-modulated inflammatory biomarkers.Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor α (ERRα) cellular localization and inhibits its transcriptional activity.Progesterone--promoter or inhibitor of breast cancer.Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer.Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells.Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cellsSLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.Syndecan-1 and syndecan-4 are independent indicators in breast carcinomaBreast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36)Heparan sulfate and heparanase as modulators of breast cancer progressionIGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM moleculesThe complex nature of oestrogen signalling in breast cancer: enemy or ally?Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk.The exposure of breast cancer cells to fulvestrant and tamoxifen modulates cell migration differently.Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation.Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours.Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression.Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.Intracellular Wnt/Beta-Catenin Signaling Underlying 17beta-Estradiol-Induced Matrix Metalloproteinase 9 Expression in Human Endometriosis.
P2860
Q26739969-A41D45C6-88FE-4239-9635-C866E1753345Q28085548-BAE2AC8F-92BC-42E0-B7E7-BBE75173BEB2Q28476759-679B9385-2A05-4A53-AEA9-87300F2A2A9BQ33972081-8BAA0DB2-8D8D-4C92-898E-950A15A1BBBDQ34031745-F579F931-5AD2-4853-A8A6-050654967CBEQ34113871-ED6F3FD6-20AE-4293-AF11-AE96E6A16445Q34156903-BB0B40F3-4CB6-435A-B725-9D60A7D34F74Q34323606-8EC272CB-B96C-4123-A8B8-16E311C1576EQ34452797-85E3A2CD-E0E8-4572-BB00-CC6AE3429F66Q34475894-85620187-3D20-4CB4-8A67-5424859B0A19Q35036132-BDF0DD05-69D1-4654-9D60-83E624329056Q35085094-FF00FF5A-D8D9-4F4D-B8A3-08ED83DB275BQ35213098-A1F1F2CA-8B0A-4A56-877D-F3ED87AFE9CBQ35441324-F80DAC74-A00C-4079-ACA7-06AD927F2D16Q35768137-AD041087-FEDA-46A7-85FD-24748C89532EQ35802058-18068EF2-0548-4E44-B4B8-8D60A63697FFQ37105315-D8E81CD2-D8E0-46EF-8224-0F1C428F0AFFQ37581720-E1ACEB03-0E85-4CC8-A935-7602264E4191Q37626856-EE42F4C8-634C-477D-92AA-675869DF7111Q38616484-2DDCC11D-1D7F-43D1-A118-5851D4F9BA43Q39111584-70F43D04-AA01-436D-992A-A87BD481E114Q39216398-D55DFF8C-50DA-4F04-BD2B-856F7CC0FD50Q39328629-9E202CCF-937E-4DC7-A20F-36A2029C0A04Q39784708-5394D02D-50C6-4A37-8B70-AF75D2BC29DBQ41444734-BA30F89B-7B5E-41AD-8474-5A16D2D99717Q46121051-E0CD318E-BF10-40CB-8EE9-D375C3FAF6D5Q47756248-375BBFAF-54B1-4156-838A-3B9A271B0185Q53081280-75614829-D3D1-4C27-AB1B-47B404271FB1Q53121884-CCED445D-0E40-49E6-8768-9D563F7665B0Q53173976-69C53EA8-FD8F-441F-9EDE-737A8E70BFF9
P2860
Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Estradiol-estrogen receptor: a ...... inase-9 in breast cancer cells
@en
type
label
Estradiol-estrogen receptor: a ...... inase-9 in breast cancer cells
@en
prefLabel
Estradiol-estrogen receptor: a ...... inase-9 in breast cancer cells
@en
P2093
P2860
P1433
P1476
Estradiol-estrogen receptor: a ...... inase-9 in breast cancer cells
@en
P2093
Achilleas D Theocharis
Aikaterini Berdiaki
Alexandros Zafiropoulos
Dimitris Kletsas
George N Tzanakakis
Nikos K Karamanos
Olga Ch Kousidou
P2860
P304
P356
10.1016/J.MOLONC.2008.06.002
P577
2008-06-18T00:00:00Z